• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

Rifabutin

CAS No. 72559-06-9

Rifabutin ( Ansamycin; LM-427 )

产品货号. M15779 CAS No. 72559-06-9

A semisynthetic ansamycin antibiotic with potent antimycobacterial properties.

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
25MG ¥340 有现货
50MG ¥446 有现货
100MG ¥640 有现货
200MG ¥1142 有现货
500MG ¥1928 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    Rifabutin
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    A semisynthetic ansamycin antibiotic with potent antimycobacterial properties.
  • 产品描述
    A semisynthetic ansamycin antibiotic with potent antimycobacterial properties. Bacterial Infection Approved
  • 同义词
    Ansamycin; LM-427
  • 通路
    GPCR/G Protein
  • 靶点
    Antibacterial
  • 受体
    Endoplasmin;HSP90;RNApolymerase
  • 研究领域
    Infection
  • 适应症
    Bacterial Infection

化学信息

  • CAS Number
    72559-06-9
  • 分子量
    847.00
  • 分子式
    C46H62N4O11
  • 纯度
    >98% (HPLC)
  • 溶解度
    10 mM in DMSO
  • SMILES
    O=C1c2c(O)c(C)c3c(C4=O)c2C5=NC6(CCN(CC(C)C)CC6)NC5=C1NC(/C(C)=C/C=C/[C@@H]([C@H](O)[C@H]([C@@H](O)[C@H]([C@@H]([C@H](C)[C@@H](OC)/C=C/O[C@]4(O3)C)OC(C)=O)C)C)C)=O
  • 化学全称
    Spiro[9,4-(epoxypentadeca[1,11,13]trienimino)-2H-furo[2',3':7,8]naphth[1,2-d]imidazole-2,4'-piperidine]-5,10,26(3H,9H)-trione, 16-(acetyloxy)-6,18,20-trihydroxy-14-methoxy-7,9,15,17,19,21,25-heptamethyl-1'-(2-methylpropyl)-, (9S,12E,14S,15R,16S,17R,18R,19

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

产品手册
关联产品
  • 5,7-Dihydroxycoumari...

    5,7-Dihydroxycoumarin is a natural product isolated from the dichloromethane extract of the inflorescences of Macaranga triloba.

  • Nevadensin

    Nevadensin is a naturally occurring selective inhibitor of human carboxylesterase 1 (hCE1) with an IC50 of 2.64 μM. Nevadensin has a variety of pharmacological effects such as anti-mycobacterium tuberculosis activities, antitussive, anti-inflammatory and anti-hypertensive.

  • Contezolid

    Contezolid (MRX I) is an orally active oxazolidinone agent with antibacterial activity Gram-positive pathogens, including MRSA, penicillin-PRSP, PISP, and vancomycin-resistant enterococci (VRE) with MIC of 0.25-4 ug/mL.